Both quantitative RT-PCR and western blotting revealed that C14orf166 was upregulated in the bladder cancer cell lines (Fig. 1a, b), suggesting that C14orf166 may contribute to the progression of bladder cancer. This evidence concerns the gene RTRAF and urinary bladder carcinoma.